Healthcare provider profile · identity verified

Ellen M Eichler, MD

Internal Medicine · TUCSON, AZ · NPI 1164478202

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	688	186
Atorvastatin Calcium	Atorvastatin Calcium	585	168
Amlodipine Besylate	Amlodipine Besylate	474	140
Losartan Potassium	Losartan Potassium	421	126
Simvastatin	Simvastatin	332	89
Gabapentin	Gabapentin	331	95
Rosuvastatin Calcium	Rosuvastatin Calcium	259	83
Metformin Hcl	Metformin Hcl	233	69
Lisinopril	Lisinopril	220	63
Alendronate Sodium	Alendronate Sodium	210	59
Omeprazole	Omeprazole	206	62
Trazodone Hcl	Trazodone Hcl	186	49
Montelukast Sodium	Montelukast Sodium	185	54
Fluoxetine Hcl	Fluoxetine Hcl	172	48
Pravastatin Sodium	Pravastatin Sodium	170	51
Duloxetine Hcl	Duloxetine Hcl	158	47
Pantoprazole Sodium	Pantoprazole Sodium	135	42
Valsartan	Valsartan	130	37
Allopurinol	Allopurinol	127	36
Metoprolol Tartrate	Metoprolol Tartrate	126	34
Hydrochlorothiazide	Hydrochlorothiazide	124	34
Bupropion Xl	Bupropion Hcl	122	33
Albuterol Sulfate Hfa	Albuterol Sulfate	121	54
Metformin Hcl Er	Metformin Hcl	111	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	20
Ezetimibe	Ezetimibe	101	35
Escitalopram Oxalate	Escitalopram Oxalate	97	24
Sertraline Hcl	Sertraline Hcl	94	26
Alprazolam	Alprazolam	91	31
Metoprolol Succinate	Metoprolol Succinate	87	31
Citalopram Hbr	Citalopram Hydrobromide	84	24
Azelastine Hcl	Azelastine Hcl	82	25
Tramadol Hcl	Tramadol Hcl	81	22
Cephalexin	Cephalexin	79	57
Eliquis	Apixaban	77	27
Lovastatin	Lovastatin	77	20
Buspirone Hcl	Buspirone Hcl	74	19
Estradiol	Estradiol	74	30
Olmesartan Medoxomil	Olmesartan Medoxomil	73	19
Venlafaxine Hcl Er	Venlafaxine Hcl	73	23
Famotidine	Famotidine	72	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	72	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	64	56
Potassium Chloride	Potassium Chloride	59	17
Synthroid	Levothyroxine Sodium	58	15
Furosemide	Furosemide	55	19
Tamsulosin Hcl	Tamsulosin Hcl	55	20
Warfarin Sodium	Warfarin Sodium	55	suppressed
Atenolol	Atenolol	53	15
Finasteride	Finasteride	50	14
Ozempic	Semaglutide	50	suppressed
Valacyclovir	Valacyclovir Hcl	50	22
Azithromycin	Azithromycin	46	41
Clopidogrel	Clopidogrel Bisulfate	45	15
Donepezil Hcl	Donepezil Hcl	45	12
Prednisone	Prednisone	45	33
Zolpidem Tartrate	Zolpidem Tartrate	45	16
Xarelto	Rivaroxaban	40	suppressed
Glimepiride	Glimepiride	39	11
Temazepam	Temazepam	39	suppressed
Nebivolol Hcl	Nebivolol Hcl	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Carvedilol	Carvedilol	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Glipizide	Glipizide	36	12
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Meloxicam	Meloxicam	33	17
Diazepam	Diazepam	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	31	31
Benazepril Hcl	Benazepril Hcl	30	suppressed
Glipizide Er	Glipizide	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Acyclovir	Acyclovir	27	11
Dicyclomine Hcl	Dicyclomine Hcl	27	11
Gemfibrozil	Gemfibrozil	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	25
Clonazepam	Clonazepam	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Celecoxib	Celecoxib	25	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	24	24
Triamcinolone Acetonide	Triamcinolone Acetonide	24	22
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Prolia	Denosumab	22	13
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Estradiol (Twice Weekly)	Estradiol	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Linzess	Linaclotide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	13
Repatha Sureclick	Evolocumab	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Yuvafem	Estradiol	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Ketoconazole	Ketoconazole	12	12
Ramipril	Ramipril	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glyburide	Glyburide	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Roflumilast	Roflumilast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error